Vatelizumab
From Wikipedia, the free encyclopedia
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized |
| Target | integrin alpha 2 |
| Identifiers | |
| CAS Number | 1238217-55-4  |
| ATC code | none |
| ChemSpider | none |
 (what is this?) (verify) |
|
Vatelizumab is an immunomodulator. It binds to integrin alpha 2.[1]
References[edit]
- ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2).
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
